KARAMOUZIS, IOANNIS
KARAMOUZIS, IOANNIS
SCIENZE MEDICHE
*ASSESSMENT OF BONE BIOCHEMICAL INDICATORS IN THALASSAEMIA AND SICKLE CELL ANEMIA*
2010-01-01 *K.Thisiadou;I.Karamouzis;S.Arampatzi;M.Karamouzis.*
*Calcium-phosphorus metabolism and parathyroid function in patients with end stage chronic kidney disease*
2010-01-01 *I.Karamouzis ;K.Thisiadou;S.Arampatzi;D.Michailidou*
ACUTE ADMINISTRATION OF ALPRAZOLAM, A BENZODIAZEPINE ACTIVATING GABA RECEPTORS, INHIBITS CORTISOL SECRETION IN PATIENTS WITH SUBCLINICAL BUT NOT OVERT CUSHING'S SYNDROME
2013-01-01 R. Giordano; R. Berardelli; I. Karamouzis; V. D’Angelo; A. Picu; C. Zichi.; B. Fussotto; M. Manzo; G. Mengozzi; E. Ghigo; E. Arvat
BCLI POLYMORPHISM OF THE GLUCOCORTICOID RECEPTOR GENE IS ASSOCIATED WITH INCREASED OBESITY, IMPAIRED GLUCOSE TOLERANCE AND DYSLIPIDEMIA IN PATIENTS WITH ADDISON’S DISEASE
2012-01-01 R. Giordano; S. Marzotti; R. Berardelli; I. Karamouzis; A. Brozzetti; V. D’Angelo; G. Mengozzi; G. Mandrile; D. Giachino; G. Migliaretti; V. Bini; A. Falorni; E. Ghigo; E. Arvat
CUSHING'S SYNDROME IS ASSOCIATED WITH SLEEP ALTERATIONS DETECTED BY WRIST ACTIGRAPHY
2015-01-01 D'Angelo, V; Beccuti, G; Berardelli, R; Karamouzis, I; Zichi, C; Giordano, R; Minetto, Ma; Maccario, M; Ghigo, E; Arvat, E
DUAL-RELEASE HYDROCORTISONE IN ADDISON’S DISEASE-A REVIEW OF THE LITERATURE
2014-01-01 R. Giordano; F. Guaraldi; R. Berardelli; I Karamouzis; V. D’Angelo; C. Zichi; S. Grottoli; E. Ghigo; E. Arvat
Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamus-pituitary-adrenal (HPA) axis in humans
2010-01-01 R. Berardelli; I. Karamouzis; E. Marinazzo; E. Prats; A. Picu; R. Giordano; E. Ghigo; E. Arvat
EFFECT OF PROLONGED TREATMENT WITH POTASSIUM CANRENOATE, A MR ANTAGONIST, ON BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS
2009-01-01 R. Berardelli; E. Marinazzo; E. Prats; A. Picu; R. Giordano; I. Karamouzis; E. Ghigo; E Arvat
EFFECTS OF CETRORELIX, A GnRH-RECEPTOR ANTAGONIST, ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA
2011-01-01 R. Berardelli; L. Gianotti; I. Karamouzis; A. Picu; R. Giordano; V. D'Angelo; D. Zinnà; F. Lanfranco; E. Ghigo; E. Arvat
Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome.
2015-01-01 I. Karamouzis; R. Berardelli; V. D'Angelo; B. Fussotto; C. Zichi; R. Giordano; F. Settanni; M. Maccario; E. Ghigo; E. Arvat
GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY
2011-01-01 R. Giordano; S. Marzotti; R. Berardelli; I. Karamouzis; E. Marinazzo; A. Picu; D. Forno; D. Zinnà; D. Giachino; A. Falorni; E. Ghigo; E. Arvat
IMPROVEMENT OF ANTHROPOMETRIC AND METABOLIC PARAMETERS, AND QUALITY OF LIFE FOLLOWING TREATMENT WITH DUAL-RELEASE HYDROCORTISONE IN PATIENTS WITH ADDISON'S DISEASE
2016-01-01 Giordano, R; Guaraldi, F; Marinazzo, E; Fumarola, F; Rampino, A; Berardelli, R; Karamouzis, I; Lucchiari, M; Manetta, T; Mengozzi, G; Arvat, E; Ghigo, E
METABOLIC AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT AETIOLOGY DURING ACTIVE DISEASE AND 1 YEAR AFTER REMISSION
2011-01-01 R. Giordano; A. Picu; E. Marinazzo; V. D'Angelo; R. Berardelli; I. Karamouzis; D.Forno; D. Zinnà; M. Maccario; E. Ghigo; E. Arvat
METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION
2010-01-01 A. Picu; E. Marinazzo; M. Balbo; R. Berardelli; I. Karamouzis; E. Ghigo; R. Giordano; E. Arvat
Neuroendocrine effects of citalopram, a selective serotonine re-uptake inhibitor, during life span in humans
2010-01-01 R. Berardelli; E. Margarito; F. Ghiggia; A. Picu; M. Balbo; L. Bonelli; R. Giordano; I. Karamouzis; M. Bo; E. Ghigo; E. Arvat
Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas
2015-01-01 Karamouzis, I; Berardelli, R.; Prencipe, N.; Berton, A.; Bona, C.; Stura, G.; Corsico, M.; Gasco, V.; Maccario, M.; Ghigo, E.; Grottoli, S.
Secondary adrenal insufficiency: Where is it hidden and what does it look like?
2016-01-01 Guaraldi, Federica; Karamouzis, Ioannis; Berardelli, Rita; D'Angelo, Valentina; Rampino, Alessia; Zichi, Clizia; Ghigo, Ezio; Giordano, Roberta
SECONDARY ADRENAL INSUFFICIENCY: WHERE IT IS HIDDEN AND HOW IT LOOKS
2016-01-01 Guaraldi, F.; Karamouzis, I.; Berardelli, R.; D’Angelo, V.; Fumarola, F.; Rampino, A.; Zichi, C.; Ghigo and R Giordano, E. Ghigo and R. Giordano
THE ACUTE EFFECT OF A MINERALOCORTICOID RECEPTOR AGONIST ON CORTICOTROPE SECRETION IN ADDISON'S DISEASE
2016-01-01 Berardelli, R.; Karamouzis, I.; D'Angelo, V.; Fussotto, B.; Minetto, M.A.; Ghigo, E.; Giordano, R.; Arvat, E.
THE ACUTE EFFECT OF FLUDROCORTISONE ON BASAL AND HCRH-STIMULATED HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS
2013-01-01 Karamouzis I; Berardelli R; Marinazzo E; D'Angelo V; Zinnà D; Minetto MA; Zichi C; Fussotto B; Giordano R; Ghigo E; Arvat E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| *ASSESSMENT OF BONE BIOCHEMICAL INDICATORS IN THALASSAEMIA AND SICKLE CELL ANEMIA* | 2010 | *K.Thisiadou;I.Karamouzis;S.Arampatzi;M.Karamouzis.* | |
| *Calcium-phosphorus metabolism and parathyroid function in patients with end stage chronic kidney disease* | 2010 | *I.Karamouzis ;K.Thisiadou;S.Arampatzi;D.Michailidou* | |
| ACUTE ADMINISTRATION OF ALPRAZOLAM, A BENZODIAZEPINE ACTIVATING GABA RECEPTORS, INHIBITS CORTISOL SECRETION IN PATIENTS WITH SUBCLINICAL BUT NOT OVERT CUSHING'S SYNDROME | 2013 | R. Giordano; R. Berardelli; I. Karamouzis; V. D’Angelo; A. Picu; C. Zichi.; B. Fussotto; M. Manzo; G. Mengozzi; E. Ghigo; E. Arvat | |
| BCLI POLYMORPHISM OF THE GLUCOCORTICOID RECEPTOR GENE IS ASSOCIATED WITH INCREASED OBESITY, IMPAIRED GLUCOSE TOLERANCE AND DYSLIPIDEMIA IN PATIENTS WITH ADDISON’S DISEASE | 2012 | R. Giordano; S. Marzotti; R. Berardelli; I. Karamouzis; A. Brozzetti; V. D’Angelo; G. Mengozzi; G. Mandrile; D. Giachino; G. Migliaretti; V. Bini; A. Falorni; E. Ghigo; E. Arvat | |
| CUSHING'S SYNDROME IS ASSOCIATED WITH SLEEP ALTERATIONS DETECTED BY WRIST ACTIGRAPHY | 2015 | D'Angelo, V; Beccuti, G; Berardelli, R; Karamouzis, I; Zichi, C; Giordano, R; Minetto, Ma; Maccario, M; Ghigo, E; Arvat, E | |
| DUAL-RELEASE HYDROCORTISONE IN ADDISON’S DISEASE-A REVIEW OF THE LITERATURE | 2014 | R. Giordano; F. Guaraldi; R. Berardelli; I Karamouzis; V. D’Angelo; C. Zichi; S. Grottoli; E. Ghigo; E. Arvat | |
| Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamus-pituitary-adrenal (HPA) axis in humans | 2010 | R. Berardelli; I. Karamouzis; E. Marinazzo; E. Prats; A. Picu; R. Giordano; E. Ghigo; E. Arvat | |
| EFFECT OF PROLONGED TREATMENT WITH POTASSIUM CANRENOATE, A MR ANTAGONIST, ON BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS | 2009 | R. Berardelli; E. Marinazzo; E. Prats; A. Picu; R. Giordano; I. Karamouzis; E. Ghigo; E Arvat | |
| EFFECTS OF CETRORELIX, A GnRH-RECEPTOR ANTAGONIST, ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA | 2011 | R. Berardelli; L. Gianotti; I. Karamouzis; A. Picu; R. Giordano; V. D'Angelo; D. Zinnà; F. Lanfranco; E. Ghigo; E. Arvat | |
| Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome. | 2015 | I. Karamouzis; R. Berardelli; V. D'Angelo; B. Fussotto; C. Zichi; R. Giordano; F. Settanni; M. Maccario; E. Ghigo; E. Arvat | |
| GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY | 2011 | R. Giordano; S. Marzotti; R. Berardelli; I. Karamouzis; E. Marinazzo; A. Picu; D. Forno; D. Zinnà; D. Giachino; A. Falorni; E. Ghigo; E. Arvat | |
| IMPROVEMENT OF ANTHROPOMETRIC AND METABOLIC PARAMETERS, AND QUALITY OF LIFE FOLLOWING TREATMENT WITH DUAL-RELEASE HYDROCORTISONE IN PATIENTS WITH ADDISON'S DISEASE | 2016 | Giordano, R; Guaraldi, F; Marinazzo, E; Fumarola, F; Rampino, A; Berardelli, R; Karamouzis, I; Lucchiari, M; Manetta, T; Mengozzi, G; Arvat, E; Ghigo, E | |
| METABOLIC AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT AETIOLOGY DURING ACTIVE DISEASE AND 1 YEAR AFTER REMISSION | 2011 | R. Giordano; A. Picu; E. Marinazzo; V. D'Angelo; R. Berardelli; I. Karamouzis; D.Forno; D. Zinnà; M. Maccario; E. Ghigo; E. Arvat | |
| METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION | 2010 | A. Picu; E. Marinazzo; M. Balbo; R. Berardelli; I. Karamouzis; E. Ghigo; R. Giordano; E. Arvat | |
| Neuroendocrine effects of citalopram, a selective serotonine re-uptake inhibitor, during life span in humans | 2010 | R. Berardelli; E. Margarito; F. Ghiggia; A. Picu; M. Balbo; L. Bonelli; R. Giordano; I. Karamouzis; M. Bo; E. Ghigo; E. Arvat | |
| Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas | 2015 | Karamouzis, I; Berardelli, R.; Prencipe, N.; Berton, A.; Bona, C.; Stura, G.; Corsico, M.; Gasco, V.; Maccario, M.; Ghigo, E.; Grottoli, S. | |
| Secondary adrenal insufficiency: Where is it hidden and what does it look like? | 2016 | Guaraldi, Federica; Karamouzis, Ioannis; Berardelli, Rita; D'Angelo, Valentina; Rampino, Alessia; Zichi, Clizia; Ghigo, Ezio; Giordano, Roberta | |
| SECONDARY ADRENAL INSUFFICIENCY: WHERE IT IS HIDDEN AND HOW IT LOOKS | 2016 | Guaraldi, F.; Karamouzis, I.; Berardelli, R.; D’Angelo, V.; Fumarola, F.; Rampino, A.; Zichi, C.; Ghigo and R Giordano, E. Ghigo and R. Giordano | |
| THE ACUTE EFFECT OF A MINERALOCORTICOID RECEPTOR AGONIST ON CORTICOTROPE SECRETION IN ADDISON'S DISEASE | 2016 | Berardelli, R.; Karamouzis, I.; D'Angelo, V.; Fussotto, B.; Minetto, M.A.; Ghigo, E.; Giordano, R.; Arvat, E. | |
| THE ACUTE EFFECT OF FLUDROCORTISONE ON BASAL AND HCRH-STIMULATED HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS | 2013 | Karamouzis I; Berardelli R; Marinazzo E; D'Angelo V; Zinnà D; Minetto MA; Zichi C; Fussotto B; Giordano R; Ghigo E; Arvat E |